Skip to main content
Fig. 3 | Cost Effectiveness and Resource Allocation

Fig. 3

From: Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting

Fig. 3

Cost Effectiveness Plane: “Base Case” Scenario. This graph plots the MCS results of 5,000 replications of IDM vs. UC in the “Base Case” scenario and plots the cost effectiveness plane against a willingness to pay (WTP) threshold of $50,000 (CAN) per QALY (k = 50,000). The ICER (Incremental Cost-Effectiveness Ratio) is akin to the ICUR (Incremental Cost-Utility Ratio) given incremental cost of IDM is plotted against incremental QALY; the ICER reflects that IDM is dominant to UC. The blue shaded area reflects the sustainability area (i.e., below the WTP threshold; P(Sustainability Area) = 0.8530). The ellipses divide the observed bivariate distribution of the outcomes (i.e., \(\mathrm{\Delta QALY},\mathrm{ \Delta Cost})\) with an estimated probability density function of a constant value. Given five areas (i.e., four ellipses), each area reflects 20% of outcomes.

Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us